nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—Nateglinide—Bortezomib—hematologic cancer	0.179	0.513	CrCrCtD
Enalapril—Aspartame—Bortezomib—hematologic cancer	0.17	0.487	CrCrCtD
Enalapril—ABCB1—hematologic cancer	0.0764	1	CbGaD
Enalapril—SLCO1A2—Chlorambucil—hematologic cancer	0.0454	0.128	CbGbCtD
Enalapril—SLC22A8—Mercaptopurine—hematologic cancer	0.0216	0.0611	CbGbCtD
Enalapril—SLCO1A2—Prednisolone—hematologic cancer	0.0172	0.0484	CbGbCtD
Enalapril—SLCO1A2—Prednisone—hematologic cancer	0.0162	0.0457	CbGbCtD
Enalapril—ABCB1—Lenalidomide—hematologic cancer	0.0148	0.0418	CbGbCtD
Enalapril—SLC22A7—Methotrexate—hematologic cancer	0.0116	0.0327	CbGbCtD
Enalapril—SLCO1A2—Dexamethasone—hematologic cancer	0.0101	0.0286	CbGbCtD
Enalapril—CYP3A4—Bexarotene—hematologic cancer	0.00887	0.025	CbGbCtD
Enalapril—ABCB1—Daunorubicin—hematologic cancer	0.00868	0.0245	CbGbCtD
Enalapril—ABCB1—Alitretinoin—hematologic cancer	0.0085	0.024	CbGbCtD
Enalapril—CYP3A4—Busulfan—hematologic cancer	0.00824	0.0233	CbGbCtD
Enalapril—CYP3A4—Lomustine—hematologic cancer	0.00824	0.0233	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—hematologic cancer	0.00813	0.0229	CbGbCtD
Enalapril—CYP3A4—Thiotepa—hematologic cancer	0.00735	0.0207	CbGbCtD
Enalapril—SLC22A8—Methotrexate—hematologic cancer	0.00708	0.02	CbGbCtD
Enalapril—ABCB1—Imatinib—hematologic cancer	0.00665	0.0188	CbGbCtD
Enalapril—ABCB1—Nilotinib—hematologic cancer	0.00604	0.017	CbGbCtD
Enalapril—ABCB1—Vinorelbine—hematologic cancer	0.00599	0.0169	CbGbCtD
Enalapril—CYP3A4—Methoxsalen—hematologic cancer	0.00571	0.0161	CbGbCtD
Enalapril—CYP3A4—Bortezomib—hematologic cancer	0.00543	0.0153	CbGbCtD
Enalapril—ABCB1—Dasatinib—hematologic cancer	0.00534	0.0151	CbGbCtD
Enalapril—ABCB1—Mitoxantrone—hematologic cancer	0.00527	0.0149	CbGbCtD
Enalapril—CYP3A4—Daunorubicin—hematologic cancer	0.0052	0.0147	CbGbCtD
Enalapril—SLC22A6—Methotrexate—hematologic cancer	0.00493	0.0139	CbGbCtD
Enalapril—ABCB1—Betamethasone—hematologic cancer	0.0047	0.0133	CbGbCtD
Enalapril—ABCB1—Gemcitabine—hematologic cancer	0.00466	0.0131	CbGbCtD
Enalapril—ABCB1—Prednisolone—hematologic cancer	0.00464	0.0131	CbGbCtD
Enalapril—CYP3A4—Cytarabine—hematologic cancer	0.00458	0.0129	CbGbCtD
Enalapril—CYP3A4—Teniposide—hematologic cancer	0.00452	0.0128	CbGbCtD
Enalapril—ABCB1—Prednisone—hematologic cancer	0.00438	0.0124	CbGbCtD
Enalapril—CYP3A4—Ifosfamide—hematologic cancer	0.00417	0.0118	CbGbCtD
Enalapril—ABCB1—Irinotecan—hematologic cancer	0.00415	0.0117	CbGbCtD
Enalapril—CYP3A4—Imatinib—hematologic cancer	0.00398	0.0112	CbGbCtD
Enalapril—CYP3A4—Ruxolitinib—hematologic cancer	0.00375	0.0106	CbGbCtD
Enalapril—ABCB1—Vinblastine—hematologic cancer	0.00369	0.0104	CbGbCtD
Enalapril—ABCB1—Vincristine—hematologic cancer	0.00363	0.0102	CbGbCtD
Enalapril—CYP3A4—Nilotinib—hematologic cancer	0.00362	0.0102	CbGbCtD
Enalapril—CYP3A4—Vinorelbine—hematologic cancer	0.00359	0.0101	CbGbCtD
Enalapril—ABCB1—Cisplatin—hematologic cancer	0.00338	0.00955	CbGbCtD
Enalapril—ABCB1—Etoposide—hematologic cancer	0.00332	0.00939	CbGbCtD
Enalapril—CYP3A4—Triamcinolone—hematologic cancer	0.00328	0.00926	CbGbCtD
Enalapril—CYP3A4—Dasatinib—hematologic cancer	0.0032	0.00903	CbGbCtD
Enalapril—CYP3A4—Mitoxantrone—hematologic cancer	0.00316	0.00892	CbGbCtD
Enalapril—CYP3A4—Betamethasone—hematologic cancer	0.00282	0.00795	CbGbCtD
Enalapril—CYP3A4—Prednisolone—hematologic cancer	0.00278	0.00784	CbGbCtD
Enalapril—ABCB1—Dexamethasone—hematologic cancer	0.00273	0.00772	CbGbCtD
Enalapril—CYP3A4—Prednisone—hematologic cancer	0.00262	0.00741	CbGbCtD
Enalapril—CYP3A4—Irinotecan—hematologic cancer	0.00249	0.00702	CbGbCtD
Enalapril—ABCB1—Doxorubicin—hematologic cancer	0.00227	0.0064	CbGbCtD
Enalapril—CYP3A4—Vinblastine—hematologic cancer	0.00221	0.00624	CbGbCtD
Enalapril—ABCB1—Methotrexate—hematologic cancer	0.0022	0.0062	CbGbCtD
Enalapril—CYP3A4—Vincristine—hematologic cancer	0.00217	0.00614	CbGbCtD
Enalapril—CYP3A4—Etoposide—hematologic cancer	0.00199	0.00562	CbGbCtD
Enalapril—CYP3A4—Dexamethasone—hematologic cancer	0.00164	0.00462	CbGbCtD
Enalapril—CYP3A4—Doxorubicin—hematologic cancer	0.00136	0.00384	CbGbCtD
Enalapril—Benazepril—MTHFR—hematologic cancer	0.000286	0.271	CrCbGaD
Enalapril—Captopril—ALB—hematologic cancer	0.000198	0.187	CrCbGaD
Enalapril—Captopril—ABCB1—hematologic cancer	0.000189	0.179	CrCbGaD
Enalapril—SLCO1A2—hematopoietic system—hematologic cancer	0.000148	0.0884	CbGeAlD
Enalapril—SLC22A8—hematopoietic system—hematologic cancer	0.000142	0.0844	CbGeAlD
Enalapril—ACE—hematopoietic system—hematologic cancer	0.000141	0.0841	CbGeAlD
Enalapril—SLC22A7—testis—hematologic cancer	0.000134	0.08	CbGeAlD
Enalapril—Perindopril—ABCB1—hematologic cancer	0.000119	0.113	CrCbGaD
Enalapril—ACE—gonad—hematologic cancer	0.000107	0.0639	CbGeAlD
Enalapril—Cilazapril—ABCB1—hematologic cancer	0.000105	0.0992	CrCbGaD
Enalapril—Lisinopril—ABCB1—hematologic cancer	0.000105	0.0992	CrCbGaD
Enalapril—SLC22A8—blood—hematologic cancer	9.39e-05	0.0559	CbGeAlD
Enalapril—ACE—blood—hematologic cancer	9.36e-05	0.0557	CbGeAlD
Enalapril—ACE—bone marrow—hematologic cancer	9.05e-05	0.0539	CbGeAlD
Enalapril—SLCO1A2—lung—hematologic cancer	8.62e-05	0.0513	CbGeAlD
Enalapril—ACE—lung—hematologic cancer	8.2e-05	0.0488	CbGeAlD
Enalapril—SLCO1A2—testis—hematologic cancer	8.13e-05	0.0484	CbGeAlD
Enalapril—ACE—testis—hematologic cancer	7.74e-05	0.0461	CbGeAlD
Enalapril—CYP3A4—hematopoietic system—hematologic cancer	7.02e-05	0.0418	CbGeAlD
Enalapril—ACE—lymph node—hematologic cancer	5.61e-05	0.0334	CbGeAlD
Enalapril—Nateglinide—ALB—hematologic cancer	5.5e-05	0.0521	CrCbGaD
Enalapril—ABCB1—hematopoietic system—hematologic cancer	4.97e-05	0.0296	CbGeAlD
Enalapril—CYP3A4—blood—hematologic cancer	4.65e-05	0.0277	CbGeAlD
Enalapril—ABCB1—gonad—hematologic cancer	3.78e-05	0.0225	CbGeAlD
Enalapril—ABCB1—blood—hematologic cancer	3.29e-05	0.0196	CbGeAlD
Enalapril—ABCB1—bone marrow—hematologic cancer	3.19e-05	0.019	CbGeAlD
Enalapril—ABCB1—lung—hematologic cancer	2.89e-05	0.0172	CbGeAlD
Enalapril—ABCB1—testis—hematologic cancer	2.72e-05	0.0162	CbGeAlD
Enalapril—ABCB1—lymph node—hematologic cancer	1.97e-05	0.0118	CbGeAlD
Enalapril—Dyspepsia—Dexamethasone—hematologic cancer	1.65e-05	9.05e-05	CcSEcCtD
Enalapril—Dyspepsia—Betamethasone—hematologic cancer	1.65e-05	9.05e-05	CcSEcCtD
Enalapril—Urticaria—Triamcinolone—hematologic cancer	1.65e-05	9e-05	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—hematologic cancer	1.64e-05	8.98e-05	CcSEcCtD
Enalapril—Asthenia—Etoposide—hematologic cancer	1.64e-05	8.96e-05	CcSEcCtD
Enalapril—Body temperature increased—Triamcinolone—hematologic cancer	1.64e-05	8.95e-05	CcSEcCtD
Enalapril—Oedema—Prednisone—hematologic cancer	1.64e-05	8.95e-05	CcSEcCtD
Enalapril—Anaphylactic shock—Prednisone—hematologic cancer	1.64e-05	8.95e-05	CcSEcCtD
Enalapril—Decreased appetite—Dexamethasone—hematologic cancer	1.63e-05	8.93e-05	CcSEcCtD
Enalapril—Decreased appetite—Betamethasone—hematologic cancer	1.63e-05	8.93e-05	CcSEcCtD
Enalapril—Nausea—Mitoxantrone—hematologic cancer	1.63e-05	8.92e-05	CcSEcCtD
Enalapril—Nausea—Irinotecan—hematologic cancer	1.63e-05	8.92e-05	CcSEcCtD
Enalapril—Back pain—Methotrexate—hematologic cancer	1.62e-05	8.87e-05	CcSEcCtD
Enalapril—Fatigue—Dexamethasone—hematologic cancer	1.62e-05	8.86e-05	CcSEcCtD
Enalapril—Fatigue—Betamethasone—hematologic cancer	1.62e-05	8.86e-05	CcSEcCtD
Enalapril—Pruritus—Etoposide—hematologic cancer	1.62e-05	8.83e-05	CcSEcCtD
Enalapril—Shock—Prednisone—hematologic cancer	1.61e-05	8.81e-05	CcSEcCtD
Enalapril—Arrhythmia—Epirubicin—hematologic cancer	1.61e-05	8.8e-05	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—hematologic cancer	1.61e-05	8.79e-05	CcSEcCtD
Enalapril—Tachycardia—Prednisone—hematologic cancer	1.6e-05	8.74e-05	CcSEcCtD
Enalapril—Alopecia—Epirubicin—hematologic cancer	1.59e-05	8.71e-05	CcSEcCtD
Enalapril—Nausea—Gemcitabine—hematologic cancer	1.59e-05	8.69e-05	CcSEcCtD
Enalapril—Vomiting—Cisplatin—hematologic cancer	1.58e-05	8.67e-05	CcSEcCtD
Enalapril—Hyperhidrosis—Prednisone—hematologic cancer	1.58e-05	8.65e-05	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—hematologic cancer	1.58e-05	8.64e-05	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—hematologic cancer	1.58e-05	8.62e-05	CcSEcCtD
Enalapril—Rash—Cisplatin—hematologic cancer	1.57e-05	8.59e-05	CcSEcCtD
Enalapril—Dermatitis—Cisplatin—hematologic cancer	1.57e-05	8.59e-05	CcSEcCtD
Enalapril—Erythema—Epirubicin—hematologic cancer	1.57e-05	8.58e-05	CcSEcCtD
Enalapril—Diarrhoea—Etoposide—hematologic cancer	1.56e-05	8.54e-05	CcSEcCtD
Enalapril—Anorexia—Prednisone—hematologic cancer	1.56e-05	8.53e-05	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—hematologic cancer	1.55e-05	8.5e-05	CcSEcCtD
Enalapril—Anaemia—Methotrexate—hematologic cancer	1.55e-05	8.47e-05	CcSEcCtD
Enalapril—Feeling abnormal—Dexamethasone—hematologic cancer	1.55e-05	8.47e-05	CcSEcCtD
Enalapril—Feeling abnormal—Betamethasone—hematologic cancer	1.55e-05	8.47e-05	CcSEcCtD
Enalapril—Flushing—Doxorubicin—hematologic cancer	1.55e-05	8.46e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—AGRN—hematologic cancer	1.55e-05	0.000453	CbGpPWpGaD
Enalapril—Flatulence—Epirubicin—hematologic cancer	1.55e-05	8.45e-05	CcSEcCtD
Enalapril—Tension—Epirubicin—hematologic cancer	1.54e-05	8.42e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Betamethasone—hematologic cancer	1.54e-05	8.4e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.54e-05	8.4e-05	CcSEcCtD
Enalapril—Dysgeusia—Epirubicin—hematologic cancer	1.54e-05	8.4e-05	CcSEcCtD
Enalapril—Hypersensitivity—Triamcinolone—hematologic cancer	1.53e-05	8.34e-05	CcSEcCtD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.52e-05	0.000447	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.52e-05	0.000447	CbGpPWpGaD
Enalapril—Nervousness—Epirubicin—hematologic cancer	1.52e-05	8.33e-05	CcSEcCtD
Enalapril—Back pain—Epirubicin—hematologic cancer	1.52e-05	8.3e-05	CcSEcCtD
Enalapril—Dizziness—Etoposide—hematologic cancer	1.51e-05	8.26e-05	CcSEcCtD
Enalapril—Muscle spasms—Epirubicin—hematologic cancer	1.51e-05	8.25e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	1.51e-05	0.000441	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	1.51e-05	0.000441	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL1B—hematologic cancer	1.51e-05	0.000441	CbGpPWpGaD
Enalapril—Vertigo—Methotrexate—hematologic cancer	1.51e-05	8.23e-05	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—CASP3—hematologic cancer	1.5e-05	0.00044	CbGpPWpGaD
Enalapril—Leukopenia—Methotrexate—hematologic cancer	1.5e-05	8.2e-05	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—IL2—hematologic cancer	1.5e-05	0.000439	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	1.49e-05	0.000438	CbGpPWpGaD
Enalapril—Urticaria—Dexamethasone—hematologic cancer	1.49e-05	8.16e-05	CcSEcCtD
Enalapril—Urticaria—Betamethasone—hematologic cancer	1.49e-05	8.16e-05	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.49e-05	8.15e-05	CcSEcCtD
Enalapril—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.49e-05	0.000437	CbGpPWpGaD
Enalapril—Dizziness—Prednisolone—hematologic cancer	1.49e-05	8.14e-05	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—hematologic cancer	1.49e-05	8.14e-05	CcSEcCtD
Enalapril—Asthenia—Triamcinolone—hematologic cancer	1.49e-05	8.13e-05	CcSEcCtD
Enalapril—Body temperature increased—Betamethasone—hematologic cancer	1.49e-05	8.12e-05	CcSEcCtD
Enalapril—Abdominal pain—Dexamethasone—hematologic cancer	1.49e-05	8.12e-05	CcSEcCtD
Enalapril—Body temperature increased—Dexamethasone—hematologic cancer	1.49e-05	8.12e-05	CcSEcCtD
Enalapril—Abdominal pain—Betamethasone—hematologic cancer	1.49e-05	8.12e-05	CcSEcCtD
Enalapril—Nausea—Cisplatin—hematologic cancer	1.48e-05	8.1e-05	CcSEcCtD
Enalapril—Insomnia—Prednisone—hematologic cancer	1.48e-05	8.09e-05	CcSEcCtD
Enalapril—Vision blurred—Epirubicin—hematologic cancer	1.48e-05	8.08e-05	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—hematologic cancer	1.47e-05	8.06e-05	CcSEcCtD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.47e-05	0.000431	CbGpPWpGaD
Enalapril—Paraesthesia—Prednisone—hematologic cancer	1.47e-05	8.04e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—IDH2—hematologic cancer	1.47e-05	0.000429	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HMMR—hematologic cancer	1.47e-05	0.000429	CbGpPWpGaD
Enalapril—Pruritus—Triamcinolone—hematologic cancer	1.47e-05	8.01e-05	CcSEcCtD
Enalapril—Cough—Methotrexate—hematologic cancer	1.46e-05	8e-05	CcSEcCtD
Enalapril—Vomiting—Etoposide—hematologic cancer	1.45e-05	7.94e-05	CcSEcCtD
Enalapril—Erythema—Doxorubicin—hematologic cancer	1.45e-05	7.94e-05	CcSEcCtD
Enalapril—Anaemia—Epirubicin—hematologic cancer	1.45e-05	7.93e-05	CcSEcCtD
Enalapril—Agitation—Epirubicin—hematologic cancer	1.44e-05	7.88e-05	CcSEcCtD
Enalapril—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.44e-05	0.000422	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.44e-05	0.000422	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.44e-05	0.000422	CbGpPWpGaD
Enalapril—Dyspepsia—Prednisone—hematologic cancer	1.44e-05	7.88e-05	CcSEcCtD
Enalapril—Rash—Etoposide—hematologic cancer	1.44e-05	7.87e-05	CcSEcCtD
Enalapril—Dermatitis—Etoposide—hematologic cancer	1.44e-05	7.87e-05	CcSEcCtD
Enalapril—Headache—Etoposide—hematologic cancer	1.43e-05	7.82e-05	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—hematologic cancer	1.43e-05	7.82e-05	CcSEcCtD
Enalapril—Chest pain—Methotrexate—hematologic cancer	1.43e-05	7.8e-05	CcSEcCtD
Enalapril—Myalgia—Methotrexate—hematologic cancer	1.43e-05	7.8e-05	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—hematologic cancer	1.43e-05	7.8e-05	CcSEcCtD
Enalapril—Tension—Doxorubicin—hematologic cancer	1.42e-05	7.79e-05	CcSEcCtD
Enalapril—Decreased appetite—Prednisone—hematologic cancer	1.42e-05	7.78e-05	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—hematologic cancer	1.42e-05	7.77e-05	CcSEcCtD
Enalapril—Rash—Prednisolone—hematologic cancer	1.42e-05	7.77e-05	CcSEcCtD
Enalapril—Dermatitis—Prednisolone—hematologic cancer	1.42e-05	7.76e-05	CcSEcCtD
Enalapril—Fatigue—Prednisone—hematologic cancer	1.41e-05	7.72e-05	CcSEcCtD
Enalapril—Headache—Prednisolone—hematologic cancer	1.41e-05	7.72e-05	CcSEcCtD
Enalapril—Discomfort—Methotrexate—hematologic cancer	1.41e-05	7.71e-05	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—hematologic cancer	1.41e-05	7.71e-05	CcSEcCtD
Enalapril—Vertigo—Epirubicin—hematologic cancer	1.41e-05	7.71e-05	CcSEcCtD
Enalapril—Syncope—Epirubicin—hematologic cancer	1.41e-05	7.69e-05	CcSEcCtD
Enalapril—Leukopenia—Epirubicin—hematologic cancer	1.4e-05	7.68e-05	CcSEcCtD
Enalapril—Back pain—Doxorubicin—hematologic cancer	1.4e-05	7.68e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.4e-05	0.00041	CbGpPWpGaD
Enalapril—Constipation—Prednisone—hematologic cancer	1.4e-05	7.65e-05	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—hematologic cancer	1.4e-05	7.63e-05	CcSEcCtD
Enalapril—Palpitations—Epirubicin—hematologic cancer	1.39e-05	7.58e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.38e-05	0.000405	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.38e-05	0.000404	CbGpPWpGaD
Enalapril—Confusional state—Methotrexate—hematologic cancer	1.38e-05	7.54e-05	CcSEcCtD
Enalapril—Loss of consciousness—Epirubicin—hematologic cancer	1.38e-05	7.54e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—ARNTL—hematologic cancer	1.38e-05	0.000404	CbGpPWpGaD
Enalapril—Dizziness—Triamcinolone—hematologic cancer	1.37e-05	7.49e-05	CcSEcCtD
Enalapril—Cough—Epirubicin—hematologic cancer	1.37e-05	7.48e-05	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—hematologic cancer	1.37e-05	7.48e-05	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—hematologic cancer	1.37e-05	7.48e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.36e-05	0.000397	CbGpPWpGaD
Enalapril—Nausea—Etoposide—hematologic cancer	1.36e-05	7.42e-05	CcSEcCtD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.35e-05	0.000397	CbGpPWpGaD
Enalapril—Feeling abnormal—Prednisone—hematologic cancer	1.35e-05	7.38e-05	CcSEcCtD
Enalapril—Asthenia—Dexamethasone—hematologic cancer	1.35e-05	7.37e-05	CcSEcCtD
Enalapril—Asthenia—Betamethasone—hematologic cancer	1.35e-05	7.37e-05	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—hematologic cancer	1.34e-05	7.33e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—ACP5—hematologic cancer	1.34e-05	0.000393	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CA9—hematologic cancer	1.34e-05	0.000393	CbGpPWpGaD
Enalapril—Thrombocytopenia—Methotrexate—hematologic cancer	1.34e-05	7.32e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Prednisone—hematologic cancer	1.34e-05	7.32e-05	CcSEcCtD
Enalapril—Nausea—Prednisolone—hematologic cancer	1.34e-05	7.32e-05	CcSEcCtD
Enalapril—Myalgia—Epirubicin—hematologic cancer	1.34e-05	7.3e-05	CcSEcCtD
Enalapril—Arthralgia—Epirubicin—hematologic cancer	1.34e-05	7.3e-05	CcSEcCtD
Enalapril—Chest pain—Epirubicin—hematologic cancer	1.34e-05	7.3e-05	CcSEcCtD
Enalapril—Agitation—Doxorubicin—hematologic cancer	1.33e-05	7.29e-05	CcSEcCtD
Enalapril—Pruritus—Dexamethasone—hematologic cancer	1.33e-05	7.27e-05	CcSEcCtD
Enalapril—Pruritus—Betamethasone—hematologic cancer	1.33e-05	7.27e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—NCOR2—hematologic cancer	1.32e-05	0.000388	CbGpPWpGaD
Enalapril—Hyperhidrosis—Methotrexate—hematologic cancer	1.32e-05	7.23e-05	CcSEcCtD
Enalapril—Discomfort—Epirubicin—hematologic cancer	1.32e-05	7.21e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.32e-05	0.000386	CbGpPWpGaD
Enalapril—Vomiting—Triamcinolone—hematologic cancer	1.32e-05	7.2e-05	CcSEcCtD
Enalapril—Rash—Triamcinolone—hematologic cancer	1.31e-05	7.14e-05	CcSEcCtD
Enalapril—Dry mouth—Epirubicin—hematologic cancer	1.31e-05	7.14e-05	CcSEcCtD
Enalapril—Dermatitis—Triamcinolone—hematologic cancer	1.3e-05	7.13e-05	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—hematologic cancer	1.3e-05	7.13e-05	CcSEcCtD
Enalapril—Anorexia—Methotrexate—hematologic cancer	1.3e-05	7.13e-05	CcSEcCtD
Enalapril—Syncope—Doxorubicin—hematologic cancer	1.3e-05	7.12e-05	CcSEcCtD
Enalapril—Urticaria—Prednisone—hematologic cancer	1.3e-05	7.11e-05	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—hematologic cancer	1.3e-05	7.1e-05	CcSEcCtD
Enalapril—Headache—Triamcinolone—hematologic cancer	1.3e-05	7.1e-05	CcSEcCtD
Enalapril—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.3e-05	0.00038	CbGpPWpGaD
Enalapril—Abdominal pain—Prednisone—hematologic cancer	1.29e-05	7.08e-05	CcSEcCtD
Enalapril—Body temperature increased—Prednisone—hematologic cancer	1.29e-05	7.08e-05	CcSEcCtD
Enalapril—Confusional state—Epirubicin—hematologic cancer	1.29e-05	7.06e-05	CcSEcCtD
Enalapril—Diarrhoea—Dexamethasone—hematologic cancer	1.29e-05	7.03e-05	CcSEcCtD
Enalapril—Diarrhoea—Betamethasone—hematologic cancer	1.29e-05	7.03e-05	CcSEcCtD
Enalapril—ABCB1—Metabolism—GMPS—hematologic cancer	1.28e-05	0.000376	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—FTCD—hematologic cancer	1.28e-05	0.000376	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PHYH—hematologic cancer	1.28e-05	0.000376	CbGpPWpGaD
Enalapril—Palpitations—Doxorubicin—hematologic cancer	1.28e-05	7.01e-05	CcSEcCtD
Enalapril—Oedema—Epirubicin—hematologic cancer	1.28e-05	7e-05	CcSEcCtD
Enalapril—Anaphylactic shock—Epirubicin—hematologic cancer	1.28e-05	7e-05	CcSEcCtD
Enalapril—Hypotension—Methotrexate—hematologic cancer	1.28e-05	6.99e-05	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—hematologic cancer	1.28e-05	6.98e-05	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.27e-05	0.000373	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.27e-05	0.000372	CbGpPWpGaD
Enalapril—Cough—Doxorubicin—hematologic cancer	1.27e-05	6.93e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—IDH1—hematologic cancer	1.26e-05	0.000369	CbGpPWpGaD
Enalapril—Shock—Epirubicin—hematologic cancer	1.26e-05	6.89e-05	CcSEcCtD
Enalapril—Thrombocytopenia—Epirubicin—hematologic cancer	1.25e-05	6.85e-05	CcSEcCtD
Enalapril—Tachycardia—Epirubicin—hematologic cancer	1.25e-05	6.83e-05	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.25e-05	6.81e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—TXN—hematologic cancer	1.25e-05	0.000365	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCC3—hematologic cancer	1.25e-05	0.000365	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTO1—hematologic cancer	1.25e-05	0.000365	CbGpPWpGaD
Enalapril—Dizziness—Dexamethasone—hematologic cancer	1.24e-05	6.8e-05	CcSEcCtD
Enalapril—Dizziness—Betamethasone—hematologic cancer	1.24e-05	6.8e-05	CcSEcCtD
Enalapril—Hyperhidrosis—Epirubicin—hematologic cancer	1.24e-05	6.77e-05	CcSEcCtD
Enalapril—Insomnia—Methotrexate—hematologic cancer	1.24e-05	6.77e-05	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—hematologic cancer	1.24e-05	6.76e-05	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—hematologic cancer	1.24e-05	6.76e-05	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—hematologic cancer	1.24e-05	6.76e-05	CcSEcCtD
Enalapril—Nausea—Triamcinolone—hematologic cancer	1.23e-05	6.73e-05	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—hematologic cancer	1.23e-05	6.72e-05	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—hematologic cancer	1.22e-05	6.68e-05	CcSEcCtD
Enalapril—Anorexia—Epirubicin—hematologic cancer	1.22e-05	6.67e-05	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—hematologic cancer	1.22e-05	6.67e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—SPHK1—hematologic cancer	1.22e-05	0.000357	CbGpPWpGaD
Enalapril—Somnolence—Methotrexate—hematologic cancer	1.22e-05	6.65e-05	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.21e-05	0.000355	CbGpPWpGaD
Enalapril—Dry mouth—Doxorubicin—hematologic cancer	1.21e-05	6.61e-05	CcSEcCtD
Enalapril—Hypersensitivity—Prednisone—hematologic cancer	1.21e-05	6.59e-05	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—hematologic cancer	1.2e-05	6.58e-05	CcSEcCtD
Enalapril—Hypotension—Epirubicin—hematologic cancer	1.2e-05	6.54e-05	CcSEcCtD
Enalapril—Vomiting—Betamethasone—hematologic cancer	1.19e-05	6.53e-05	CcSEcCtD
Enalapril—Vomiting—Dexamethasone—hematologic cancer	1.19e-05	6.53e-05	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—hematologic cancer	1.19e-05	6.53e-05	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—hematologic cancer	1.19e-05	6.5e-05	CcSEcCtD
Enalapril—Rash—Betamethasone—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Enalapril—Rash—Dexamethasone—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Enalapril—Oedema—Doxorubicin—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Enalapril—Dermatitis—Dexamethasone—hematologic cancer	1.18e-05	6.47e-05	CcSEcCtD
Enalapril—Dermatitis—Betamethasone—hematologic cancer	1.18e-05	6.47e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.18e-05	0.000346	CbGpPWpGaD
Enalapril—Fatigue—Methotrexate—hematologic cancer	1.18e-05	6.45e-05	CcSEcCtD
Enalapril—Headache—Dexamethasone—hematologic cancer	1.18e-05	6.44e-05	CcSEcCtD
Enalapril—Headache—Betamethasone—hematologic cancer	1.18e-05	6.44e-05	CcSEcCtD
Enalapril—ABCB1—Metabolism—SMPD3—hematologic cancer	1.17e-05	0.000344	CbGpPWpGaD
Enalapril—Asthenia—Prednisone—hematologic cancer	1.17e-05	6.42e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—UGT1A1—hematologic cancer	1.17e-05	0.000343	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.17e-05	0.000343	CbGpPWpGaD
Enalapril—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.17e-05	6.38e-05	CcSEcCtD
Enalapril—Shock—Doxorubicin—hematologic cancer	1.17e-05	6.37e-05	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—hematologic cancer	1.16e-05	6.34e-05	CcSEcCtD
Enalapril—Pruritus—Prednisone—hematologic cancer	1.16e-05	6.33e-05	CcSEcCtD
Enalapril—Insomnia—Epirubicin—hematologic cancer	1.16e-05	6.33e-05	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—hematologic cancer	1.16e-05	6.32e-05	CcSEcCtD
Enalapril—Paraesthesia—Epirubicin—hematologic cancer	1.15e-05	6.29e-05	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.15e-05	0.000336	CbGpPWpGaD
Enalapril—Hyperhidrosis—Doxorubicin—hematologic cancer	1.14e-05	6.26e-05	CcSEcCtD
Enalapril—Dyspnoea—Epirubicin—hematologic cancer	1.14e-05	6.24e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—SLC22A1—hematologic cancer	1.14e-05	0.000334	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CRABP1—hematologic cancer	1.14e-05	0.000334	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.14e-05	0.000334	CbGpPWpGaD
Enalapril—Somnolence—Epirubicin—hematologic cancer	1.14e-05	6.22e-05	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ALB—hematologic cancer	1.13e-05	0.000332	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.13e-05	0.000332	CbGpPWpGaD
Enalapril—Anorexia—Doxorubicin—hematologic cancer	1.13e-05	6.17e-05	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—hematologic cancer	1.13e-05	6.16e-05	CcSEcCtD
Enalapril—Dyspepsia—Epirubicin—hematologic cancer	1.13e-05	6.16e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.12e-05	0.000329	CbGpPWpGaD
Enalapril—Diarrhoea—Prednisone—hematologic cancer	1.12e-05	6.12e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—hematologic cancer	1.12e-05	6.12e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.12e-05	0.000327	CbGpPWpGaD
Enalapril—Nausea—Betamethasone—hematologic cancer	1.12e-05	6.1e-05	CcSEcCtD
Enalapril—Nausea—Dexamethasone—hematologic cancer	1.12e-05	6.1e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.11e-05	0.000326	CbGpPWpGaD
Enalapril—Decreased appetite—Epirubicin—hematologic cancer	1.11e-05	6.08e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—ALOX5—hematologic cancer	1.11e-05	0.000325	CbGpPWpGaD
Enalapril—Hypotension—Doxorubicin—hematologic cancer	1.11e-05	6.05e-05	CcSEcCtD
Enalapril—Fatigue—Epirubicin—hematologic cancer	1.1e-05	6.04e-05	CcSEcCtD
Enalapril—Constipation—Epirubicin—hematologic cancer	1.09e-05	5.99e-05	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.09e-05	0.00032	CbGpPWpGaD
Enalapril—Urticaria—Methotrexate—hematologic cancer	1.09e-05	5.94e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.09e-05	0.000318	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.09e-05	0.000318	CbGpPWpGaD
Enalapril—Dizziness—Prednisone—hematologic cancer	1.08e-05	5.92e-05	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—hematologic cancer	1.08e-05	5.91e-05	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—hematologic cancer	1.08e-05	5.91e-05	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—NUP98—hematologic cancer	1.08e-05	0.000315	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.07e-05	0.000314	CbGpPWpGaD
Enalapril—Insomnia—Doxorubicin—hematologic cancer	1.07e-05	5.86e-05	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—hematologic cancer	1.06e-05	5.82e-05	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—hematologic cancer	1.06e-05	5.77e-05	CcSEcCtD
Enalapril—Feeling abnormal—Epirubicin—hematologic cancer	1.05e-05	5.77e-05	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—hematologic cancer	1.05e-05	5.76e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Epirubicin—hematologic cancer	1.05e-05	5.72e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—ADCY7—hematologic cancer	1.04e-05	0.000306	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NCOA3—hematologic cancer	1.04e-05	0.000306	CbGpPWpGaD
Enalapril—Dyspepsia—Doxorubicin—hematologic cancer	1.04e-05	5.7e-05	CcSEcCtD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.04e-05	0.000305	CbGpPWpGaD
Enalapril—Vomiting—Prednisone—hematologic cancer	1.04e-05	5.69e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—NUP214—hematologic cancer	1.04e-05	0.000304	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.03e-05	0.000303	CbGpPWpGaD
Enalapril—Rash—Prednisone—hematologic cancer	1.03e-05	5.64e-05	CcSEcCtD
Enalapril—Dermatitis—Prednisone—hematologic cancer	1.03e-05	5.64e-05	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—hematologic cancer	1.03e-05	5.63e-05	CcSEcCtD
Enalapril—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.03e-05	0.000301	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ASNS—hematologic cancer	1.03e-05	0.000301	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—DCK—hematologic cancer	1.03e-05	0.000301	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.03e-05	0.000301	CbGpPWpGaD
Enalapril—Headache—Prednisone—hematologic cancer	1.03e-05	5.61e-05	CcSEcCtD
Enalapril—Fatigue—Doxorubicin—hematologic cancer	1.02e-05	5.58e-05	CcSEcCtD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Enalapril—Urticaria—Epirubicin—hematologic cancer	1.02e-05	5.56e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—ABCG2—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTR—hematologic cancer	1.02e-05	0.000298	CbGpPWpGaD
Enalapril—Constipation—Doxorubicin—hematologic cancer	1.01e-05	5.54e-05	CcSEcCtD
Enalapril—Abdominal pain—Epirubicin—hematologic cancer	1.01e-05	5.53e-05	CcSEcCtD
Enalapril—Body temperature increased—Epirubicin—hematologic cancer	1.01e-05	5.53e-05	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—hematologic cancer	1.01e-05	5.51e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1e-05	0.000293	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ENO2—hematologic cancer	9.96e-06	0.000292	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.83e-06	0.000288	CbGpPWpGaD
Enalapril—Asthenia—Methotrexate—hematologic cancer	9.81e-06	5.37e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	9.8e-06	0.000287	CbGpPWpGaD
Enalapril—Feeling abnormal—Doxorubicin—hematologic cancer	9.76e-06	5.34e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	9.75e-06	0.000286	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HDC—hematologic cancer	9.73e-06	0.000285	CbGpPWpGaD
Enalapril—Nausea—Prednisone—hematologic cancer	9.72e-06	5.32e-05	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.68e-06	5.3e-05	CcSEcCtD
Enalapril—Pruritus—Methotrexate—hematologic cancer	9.68e-06	5.29e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—GSTT1—hematologic cancer	9.66e-06	0.000283	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	9.54e-06	0.00028	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	9.53e-06	0.000279	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.51e-06	0.000279	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	9.49e-06	0.000278	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	9.48e-06	0.000278	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SDC1—hematologic cancer	9.44e-06	0.000277	CbGpPWpGaD
Enalapril—Hypersensitivity—Epirubicin—hematologic cancer	9.43e-06	5.16e-05	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—hematologic cancer	9.41e-06	5.15e-05	CcSEcCtD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	9.39e-06	0.000275	CbGpPWpGaD
Enalapril—Body temperature increased—Doxorubicin—hematologic cancer	9.36e-06	5.12e-05	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—hematologic cancer	9.36e-06	5.12e-05	CcSEcCtD
Enalapril—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	9.36e-06	0.000274	CbGpPWpGaD
Enalapril—Diarrhoea—Methotrexate—hematologic cancer	9.36e-06	5.12e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	9.31e-06	0.000273	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	9.28e-06	0.000272	CbGpPWpGaD
Enalapril—Asthenia—Epirubicin—hematologic cancer	9.18e-06	5.02e-05	CcSEcCtD
Enalapril—Pruritus—Epirubicin—hematologic cancer	9.05e-06	4.95e-05	CcSEcCtD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.04e-06	0.000265	CbGpPWpGaD
Enalapril—Dizziness—Methotrexate—hematologic cancer	9.04e-06	4.95e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.02e-06	0.000264	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.9e-06	0.000261	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CDA—hematologic cancer	8.9e-06	0.000261	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	8.85e-06	0.000259	CbGpPWpGaD
Enalapril—Diarrhoea—Epirubicin—hematologic cancer	8.76e-06	4.79e-05	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—hematologic cancer	8.72e-06	4.77e-05	CcSEcCtD
Enalapril—Vomiting—Methotrexate—hematologic cancer	8.7e-06	4.76e-05	CcSEcCtD
Enalapril—Rash—Methotrexate—hematologic cancer	8.62e-06	4.72e-05	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—hematologic cancer	8.61e-06	4.71e-05	CcSEcCtD
Enalapril—ABCB1—Metabolism—PC—hematologic cancer	8.57e-06	0.000251	CbGpPWpGaD
Enalapril—Headache—Methotrexate—hematologic cancer	8.57e-06	4.69e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.52e-06	0.00025	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.5e-06	0.000249	CbGpPWpGaD
Enalapril—Asthenia—Doxorubicin—hematologic cancer	8.5e-06	4.65e-05	CcSEcCtD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ALB—hematologic cancer	8.47e-06	0.000248	CbGpPWpGaD
Enalapril—Dizziness—Epirubicin—hematologic cancer	8.46e-06	4.63e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	8.41e-06	0.000246	CbGpPWpGaD
Enalapril—Pruritus—Doxorubicin—hematologic cancer	8.38e-06	4.58e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	8.28e-06	0.000243	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GBA—hematologic cancer	8.28e-06	0.000243	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC35B2—hematologic cancer	8.28e-06	0.000243	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	8.27e-06	0.000242	CbGpPWpGaD
Enalapril—Vomiting—Epirubicin—hematologic cancer	8.14e-06	4.45e-05	CcSEcCtD
Enalapril—Nausea—Methotrexate—hematologic cancer	8.12e-06	4.44e-05	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—hematologic cancer	8.1e-06	4.43e-05	CcSEcCtD
Enalapril—Rash—Epirubicin—hematologic cancer	8.07e-06	4.41e-05	CcSEcCtD
Enalapril—Dermatitis—Epirubicin—hematologic cancer	8.06e-06	4.41e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—NQO1—hematologic cancer	8.03e-06	0.000235	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CD44—hematologic cancer	8.03e-06	0.000235	CbGpPWpGaD
Enalapril—Headache—Epirubicin—hematologic cancer	8.02e-06	4.39e-05	CcSEcCtD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	7.96e-06	0.000233	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GMPS—hematologic cancer	7.91e-06	0.000232	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PHYH—hematologic cancer	7.91e-06	0.000232	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—FTCD—hematologic cancer	7.91e-06	0.000232	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.86e-06	0.00023	CbGpPWpGaD
Enalapril—Dizziness—Doxorubicin—hematologic cancer	7.83e-06	4.28e-05	CcSEcCtD
Enalapril—Nausea—Epirubicin—hematologic cancer	7.6e-06	4.16e-05	CcSEcCtD
Enalapril—SLCO1A2—Metabolism—CYCS—hematologic cancer	7.6e-06	0.000223	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTAP—hematologic cancer	7.57e-06	0.000222	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	7.56e-06	0.000222	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HSP90AA1—hematologic cancer	7.55e-06	0.000221	CbGpPWpGaD
Enalapril—Vomiting—Doxorubicin—hematologic cancer	7.53e-06	4.12e-05	CcSEcCtD
Enalapril—Rash—Doxorubicin—hematologic cancer	7.47e-06	4.08e-05	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—hematologic cancer	7.46e-06	4.08e-05	CcSEcCtD
Enalapril—Headache—Doxorubicin—hematologic cancer	7.42e-06	4.06e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	7.41e-06	0.000217	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SMPD3—hematologic cancer	7.24e-06	0.000212	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	7.22e-06	0.000211	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	7.2e-06	0.000211	CbGpPWpGaD
Enalapril—Nausea—Doxorubicin—hematologic cancer	7.03e-06	3.85e-05	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	6.98e-06	0.000205	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	6.96e-06	0.000204	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.94e-06	0.000203	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	6.81e-06	0.0002	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.79e-06	0.000199	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—FHL2—hematologic cancer	6.75e-06	0.000198	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTP1—hematologic cancer	6.7e-06	0.000196	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	6.64e-06	0.000195	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AGRN—hematologic cancer	6.62e-06	0.000194	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.48e-06	0.00019	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	6.46e-06	0.000189	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCB1—hematologic cancer	6.34e-06	0.000186	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.33e-06	0.000185	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—DCK—hematologic cancer	6.33e-06	0.000185	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ASNS—hematologic cancer	6.33e-06	0.000185	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	6.29e-06	0.000184	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—IDH2—hematologic cancer	6.27e-06	0.000184	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HMMR—hematologic cancer	6.27e-06	0.000184	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NCOR1—hematologic cancer	6.15e-06	0.00018	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTM1—hematologic cancer	6.15e-06	0.00018	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HDC—hematologic cancer	6e-06	0.000176	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.95e-06	0.000174	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ARNTL—hematologic cancer	5.9e-06	0.000173	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.79e-06	0.00017	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5.77e-06	0.000169	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ACP5—hematologic cancer	5.74e-06	0.000168	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CA9—hematologic cancer	5.74e-06	0.000168	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NCOR2—hematologic cancer	5.66e-06	0.000166	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CDA—hematologic cancer	5.49e-06	0.000161	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTHFR—hematologic cancer	5.44e-06	0.000159	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—IDH1—hematologic cancer	5.39e-06	0.000158	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	5.39e-06	0.000158	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	5.35e-06	0.000157	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ABCC3—hematologic cancer	5.33e-06	0.000156	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TXN—hematologic cancer	5.33e-06	0.000156	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTO1—hematologic cancer	5.33e-06	0.000156	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PC—hematologic cancer	5.28e-06	0.000155	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SPHK1—hematologic cancer	5.22e-06	0.000153	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GBA—hematologic cancer	5.1e-06	0.000149	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.1e-06	0.000149	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.01e-06	0.000147	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.91e-06	0.000144	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.88e-06	0.000143	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CRABP1—hematologic cancer	4.88e-06	0.000143	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.79e-06	0.00014	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALOX5—hematologic cancer	4.75e-06	0.000139	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.75e-06	0.000139	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTAP—hematologic cancer	4.66e-06	0.000137	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NUP98—hematologic cancer	4.6e-06	0.000135	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	4.57e-06	0.000134	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ADCY7—hematologic cancer	4.47e-06	0.000131	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NCOA3—hematologic cancer	4.47e-06	0.000131	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NUP214—hematologic cancer	4.44e-06	0.00013	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTR—hematologic cancer	4.35e-06	0.000127	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ABCG2—hematologic cancer	4.35e-06	0.000127	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ENO2—hematologic cancer	4.26e-06	0.000125	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CREBBP—hematologic cancer	4.24e-06	0.000124	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—FHL2—hematologic cancer	4.16e-06	0.000122	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTT1—hematologic cancer	4.14e-06	0.000121	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AGRN—hematologic cancer	4.08e-06	0.000119	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SDC1—hematologic cancer	4.04e-06	0.000118	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	4.02e-06	0.000118	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.01e-06	0.000118	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALB—hematologic cancer	3.97e-06	0.000116	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.87e-06	0.000113	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—IDH2—hematologic cancer	3.86e-06	0.000113	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HMMR—hematologic cancer	3.86e-06	0.000113	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	3.79e-06	0.000111	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.63e-06	0.000106	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.62e-06	0.000106	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ACP5—hematologic cancer	3.53e-06	0.000104	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CA9—hematologic cancer	3.53e-06	0.000104	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	3.5e-06	0.000103	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.49e-06	0.000102	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NQO1—hematologic cancer	3.44e-06	0.000101	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CD44—hematologic cancer	3.44e-06	0.000101	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—IDH1—hematologic cancer	3.32e-06	9.74e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.29e-06	9.63e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TXN—hematologic cancer	3.29e-06	9.63e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.29e-06	9.63e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYCS—hematologic cancer	3.25e-06	9.53e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.23e-06	9.47e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.22e-06	9.42e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.09e-06	9.05e-05	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTEN—hematologic cancer	3.03e-06	8.86e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.01e-06	8.81e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.01e-06	8.81e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.93e-06	8.58e-05	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—EP300—hematologic cancer	2.89e-06	8.45e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTP1—hematologic cancer	2.87e-06	8.4e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NUP98—hematologic cancer	2.84e-06	8.31e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.75e-06	8.07e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.75e-06	8.07e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NUP214—hematologic cancer	2.73e-06	8.01e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTR—hematologic cancer	2.68e-06	7.85e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.68e-06	7.85e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTM1—hematologic cancer	2.63e-06	7.72e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NCOR1—hematologic cancer	2.63e-06	7.72e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ENO2—hematologic cancer	2.63e-06	7.7e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.55e-06	7.47e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SDC1—hematologic cancer	2.49e-06	7.3e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTHFR—hematologic cancer	2.33e-06	6.82e-05	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	2.13e-06	6.25e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NQO1—hematologic cancer	2.12e-06	6.2e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CD44—hematologic cancer	2.12e-06	6.2e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYCS—hematologic cancer	2e-06	5.87e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.99e-06	5.83e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.96e-06	5.73e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CREBBP—hematologic cancer	1.81e-06	5.31e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.77e-06	5.17e-05	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.74e-06	5.11e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.72e-06	5.04e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALB—hematologic cancer	1.7e-06	4.97e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.67e-06	4.9e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.62e-06	4.76e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.62e-06	4.76e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.62e-06	4.76e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.5e-06	4.39e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.43e-06	4.2e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTEN—hematologic cancer	1.3e-06	3.79e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—EP300—hematologic cancer	1.24e-06	3.62e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.21e-06	3.53e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.12e-06	3.27e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.06e-06	3.1e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALB—hematologic cancer	1.05e-06	3.06e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1e-06	2.93e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.23e-07	2.71e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.14e-07	2.68e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTEN—hematologic cancer	7.98e-07	2.34e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—EP300—hematologic cancer	7.61e-07	2.23e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKT1—hematologic cancer	7.46e-07	2.19e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.63e-07	1.65e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKT1—hematologic cancer	4.6e-07	1.35e-05	CbGpPWpGaD
